Patent · US Active

Compositions and methods related to engineered Fc constructs

US12297291B2 · kind B2 · utility

0Cited by
15References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 1, 2021
Grant dateMay 13, 2025
Priority date
Expiry dateMar 9, 2044

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to engineered IgG Fc constructs and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.